In spirit of the Super Bowl, Mad Money host Jim Cramer goes off the charts with high quality Seattle and New England based companies.
Scott Wine, Polaris Industries CEO, discusses the company's recent quarter and the headwind currencies present, with Mad Money's Jim Cramer.
In more than 30 years around Wall Street, "Mad Money" host Jim Cramer has seen a lot, but not this.
Mad Money host Jim Cramer shares his take on some of Wall Street's biggest "whiners."
Mad Money's Jim Cramer says call your broker and get a piece of Shake Shack's IPO. The deal is practically engineered to have big pop out of the gate, he says.
Mad Money host Jim Cramer Jim Cramer thinks this tape is remarkably healthy and shares 8 positive signs a market is healthy enough to invest in.
"Mad Money" host Jim Cramer thinks you should open wide and take a big bite of this new offering.
From an audio company protecting cars from cyberterrorism to a booming regional bank, CEOs give Mad Money host Jim Cramer insight into what's working.
Mad Money host Jim Cramer shares his final thoughts of the day on the weak performances by UPS and McDonald's last quarter.
Whether it's football or the stock market, leadership matters. "Mad Money" host Jim Cramer on the CEOs who have serious game.
Rick Hamada, Avnet CEO, provides insight into the company's quarter and its European business components, with Mad Money's Jim Cramer.
Mad Money host Jim Cramer looks ahead to market moving earnings, data and events set to take place next week.
Mad Money's Jim Cramer checks on the state of the semiconductor business, with Cypress Semiconductor president and CEO TJ Rodgers.
Dinesh Paliwal, Harman International Industries chairman and CEO, discusses it recent acquisitions with Symphony Teleca and Red Bend Software.
Mad Money host Jim Cramer reacts to Europe's big stimulus plan and provides perspective into the strength of the U.S.
"Mad Money" host Jim Cramer reveals how to stay out of the house of pain in this market.
Forget the haters, "Mad Money" host Jim Cramer says this stock could be a lock for the long haul.
Mad Money's Jim Cramer provides insight into upgrades by both Cowen and Stifel on Netflix.
John Crowley, Amicus Therapeutics chairman and CEO, discusses its Fabry pill development and next generation therapy for Pompe disease, with CNBC's Jim Cramer.
Mad Money host Jim Cramer focuses on the cause of today's rally. Today's strength was triggered by Netflix, says Cramer.